Together, these data suggest that downregulation of miR-129-5p and upregulation of ARID3A are responsible for the progression of ABC subtype DLBCL by promoting cell proliferation and inhibiting apoptosis. The gene discussed is ARID3A; the disease is diffuse large B-cell lymphoma.